CYPS (Cyclo 3 PSS) ROE % Adjusted to Book Value: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cyclo 3 PSS ROE % Adjusted to Book Value?

Cyclo 3 PSS CYPS -99.00% ROE % Adjusted to Book Value is 0.00% as of . 20.

Cyclo 3 PSS's ROE % for the quarter that ended in . 20 was 0.00%. Cyclo 3 PSS's PB Ratio for the quarter that ended in . 20 was N/A. Cyclo 3 PSS's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Cyclo 3 PSS ROE % Adjusted to Book Value Related Terms

Cyclo 3 PSS ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Cyclo 3 PSS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclo 3 PSS ROE % Adjusted to Book Value Chart

Cyclo 3 PSS Annual Data
Trend
ROE % Adjusted to Book Value

Cyclo 3 PSS Quarterly Data
ROE % Adjusted to Book Value

CYPS vs PSID, GBSN, ETAH: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Cyclo 3 PSS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclo 3 PSS ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cyclo 3 PSS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cyclo 3 PSS's ROE % Adjusted to Book Value falls into.


Cyclo 3 PSS ROE % Adjusted to Book Value Calculation

Cyclo 3 PSS's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Cyclo 3 PSS's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Cyclo 3 PSS (CYPS) has a ROE % Adjusted to Book Value of 0.00% as of . 20. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cyclo 3 PSS and its competitors.
Is Cyclo 3 PSS's ROE % Adjusted to Book Value too high?
Cyclo 3 PSS's current ROE % Adjusted to Book Value is 0.00%.
How does Cyclo 3 PSS's ROE % Adjusted to Book Value compare to PSID and GBSN?
Cyclo 3 PSS's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cyclo 3 PSS and its competitors. Cyclo 3 PSS's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclo 3 PSS stock overvalued right now?
Cyclo 3 PSS (CYPS) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Cyclo 3 PSS (CYPS), the current ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyclo 3 PSS Business Description

Address 7105 South Highland Drive, Suite No. 102, Salt Lake City, UT, USA, 84121
Cyclo 3 PSS Corp is engaged in the research and development of technologies for the sterilization and/or disinfection of surgical and medical instruments, the manufacture, sale and installation of ozone washing and laundry sorting & counting systems.